CORVUS PHARMACEUTICALS INC. - COMMON STOCK

Corvus Pharmaceuticals to Present at the Jefferies Healthcare Conference

31 5 2023 08:30:00 提供 Nasdaq GlobeNewswire

NetDania - New 12 months High: CORVUS PHARMACEUTICALS INC. - COMMON STOCK

18 5 2023 09:45:06 提供 NetDania Notify

NetDania - New 12 months High: CORVUS PHARMACEUTICALS INC. - COMMON STOCK

17 5 2023 10:11:07 提供 NetDania Notify

Corvus Pharmaceuticals to Present New CPI-818 Data at the International Conference on Malignant Lymphoma

17 5 2023 09:00:00 提供 Nasdaq GlobeNewswire

NetDania - New 12 months High: CORVUS PHARMACEUTICALS INC. - COMMON STOCK

15 5 2023 09:50:50 提供 NetDania Notify

NetDania - New 12 months High: CORVUS PHARMACEUTICALS INC. - COMMON STOCK

10 5 2023 09:59:55 提供 NetDania Notify

Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2023 Financial Results

08 5 2023 16:01:00 提供 Nasdaq GlobeNewswire

Corvus Pharmaceuticals to Provide Business Update and Report First Quarter 2023 Financial Results on May 8, 2023

20 4 2023 09:00:01 提供 Nasdaq GlobeNewswire

Corvus Pharmaceuticals Presents New CPI-818 Data Demonstrating the Potential of ITK Inhibition as a Treatment for Solid and Hematologic Cancers at the American Association for Cancer Research (AACR) Annual Meeting

17 4 2023 09:00:01 提供 Nasdaq GlobeNewswire

CPI-818 Data Highlights Potential for ITK Inhibition as a New Immunotherapy Approach for the Treatment of T Cell Lymphoma

03 4 2023 08:30:00 提供 Nasdaq GlobeNewswire

Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2022 Financial Results

28 3 2023 16:02:00 提供 Nasdaq GlobeNewswire

Corvus Pharmaceuticals to Provide Business Update and Report Fourth Quarter and Full Year 2022 Financial Results on March 28, 2023

21 3 2023 16:05:00 提供 Nasdaq GlobeNewswire

Corvus Pharmaceuticals to Present New CPI-818 Data Demonstrating the Potential of ITK Inhibition as a Treatment for Solid Tumors at the American Association for Cancer Research (AACR) Annual Meeting

14 3 2023 16:35:00 提供 Nasdaq GlobeNewswire

Corvus Pharmaceuticals Announces New Data Demonstrating CPI-818’s (ITK Inhibitor) Potential to Block HIV Latency Reversal

21 2 2023 07:00:01 提供 Nasdaq GlobeNewswire

Corvus Pharmaceuticals Presents Updated Data from CPI-818 (ITK Inhibitor) Phase 1/1b Clinical Trial at the 64th American Society of Hematology (ASH) Annual Meeting & Exposition

12 12 2022 10:00:00 提供 Nasdaq GlobeNewswire

Corvus Pharmaceuticals to Host Investor Conference Call and Webcast on December 12, 2022

05 12 2022 08:30:00 提供 Nasdaq GlobeNewswire

James Rosenbaum Presented the Distinguished Service Award by the American College of Rheumatology

14 11 2022 08:30:00 提供 Nasdaq GlobeNewswire

Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2022 Financial Results

03 11 2022 16:05:02 提供 Nasdaq GlobeNewswire

Corvus Pharmaceuticals to Present Updated CPI-818 (ITK Inhibitor) Data at the 64th American Society of Hematology (ASH) Annual Meeting & Exposition

03 11 2022 09:52:48 提供 Nasdaq GlobeNewswire

Corvus Pharmaceuticals to Provide Business Update and Report Third Quarter 2022 Financial Results on November 3, 2022

27 10 2022 16:05:01 提供 Nasdaq GlobeNewswire